Details of the Drug

General Information of Drug (ID: DMH32LM)

Drug Name

HRC-302

Synonyms

HML-115; XL-2; Cell therapy, X-Cell Biotech; GDT-CML, Hemosol; Stem cells, X-Cell Biotech; Gamma delta T-cells (selectively expanded), Hemosol; GDT-CML (HRC-302-expanded), Hemosol

Indication

Disease Entry	ICD 11	Status	REF
Chronic myelogenous leukaemia	2A20.0	Discontinued in Phase 1	[1]
------------------------------------------------------------------------------------

Cross-matching ID

TTD ID: D0S3WK

Molecular Interaction Atlas of This Drug

Drug Therapeutic Target (DTT)

DTT Name	DTT ID	UniProt ID	MOA	REF
Hemoglobin (HB)	TTQO71U	HBA_HUMAN	Modulator	[2]

------------------------------------------------------------------------------------

Molecular Interaction Atlas (MIA)

MIA Detail

Jump to Detail Molecular Interaction Atlas of This Drug

References

1	Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800014790)
2	Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800014790)